QIAGEN N.V. (NASDAQ:QGEN)
| CAPS Rating |
|
|---|---|
| Open | $15.42 |
| Previous Close | $15.58 |
| Daily Range | $15.09 - $15.42 |
| 52-Week Range | $12.47 - $22.20 |
| Market Cap | $3.54B |
| P/E Ratio | 23.40 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 1,653,561 |
| Average Daily Volume | 0 |
QGEN
VS S&P 500 (SPY)
How do you think QGEN will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
QGEN Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
QGEN News and Commentary
- Qiagen Beats on EPS but GAAP Results Lag – The Motley Fool
- Qiagen Posts a Solid 4Q - Analyst Blog – NASDAQ
- Myriad Beats, Raises Guidance - Analyst Blog – NASDAQ
- Hologic Tops Estimates - Analyst Blog – NASDAQ
- Cepheid Tops Estimates - Analyst Blog – NASDAQ
- Why Qiagen's Earnings Are Outstanding – The Motley Fool
- Qiagen Enhances Presence in Japan - Analyst Blog – NASDAQ
- Why Qiagen May Be About to Take Off – The Motley Fool
- Qiagen Expands QIAensemble Portfolio - Analyst Blog – NASDAQ
- FDA Nod for Hologic's Cervista HTA - Analyst Blog – NASDAQ
- Why Thermo Fisher Scientific May Be About to Take Off – The Motley Fool
- Cepheid Stays Neutral - Analyst Blog – NASDAQ
- Are You Watching This Trend at Illumina? – The Motley Fool
- How Does Thermo Fisher Scientific Boost Its Returns? – The Motley Fool
- Life Tech Launches GeneArt Kits - Analyst Blog – NASDAQ
- Does Thermo Fisher Scientific Pass Buffett's Test? – The Motley Fool
- 1 Reason Illumina May Be Headed for a Slowdown – The Motley Fool
- Is Thermo Fisher Scientific's Growth for Real? – The Motley Fool
- The 10 Fastest-Growing Biotech Equipment Stocks – The Motley Fool
- How Quickly Is the Cash Coming at Illumina? – The Motley Fool
RSS Headlines
Fool UK
